Literature DB >> 11018856

Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast.

J N Nkengasong1, L Kestens, P D Ghys, S Koblavi-Dème, R A Otten, C Bilé, C Maurice, M Kalou, M Laga, S Z Wiktor, A E Greenberg.   

Abstract

To determine the impact of dual infection with HIV-1 and HIV-2 on HIV-1 viral load and markers of immune activation among HIV-seropositive FSWs in Abidjan, we analyzed blood samples obtained from consenting HIV-seropositive FSWs attending a confidential clinic between September 1996 and June 1997 in Abidjan. Among HIV-1 and HIV-2 dually seropositive FSWs, polymerase chain reaction (PCR) testing with HIV-1 and HIV-2 primers was used to differentiate between FSWs who were PCR positive only for HIV-1 and those positive for both HIV-1 and HIV-2 (dually infected). Of the 203 FSWs, 151 (74%) were HIV-1 seropositive only (median age, 26 years), 4 (2%) were HIV-2 seropositive, and 48 (24%) were dually seropositive (median age, 30 years). Of the 48 dually seropositive FSWs, 33 (69%) were dually infected and 15 (31%) were dually seropositive. Median CD4+ T cell counts per microliter were not significantly different among the three groups (525 for HIV-1 positive only, 502 for dually infected, and 416 for dually seropositive) (p = 0.14). Median viral load (log10 copies/ml) was not significantly different among the HIV-1-only FSWs (4.8 log10 copies/ml) compared with the 32 dually infected FSWs (4.6 log10 copies/ml) and 14 dually seropositive FSWs (4.7 log10 copies/ml; p = 0.95). Median levels of HLA-DR immune activation were increased in both CD4+ and CD8+ T cells for the dually infected (n = 27) FSWs compared with those infected with HIV-1 only (n = 123) (p = 0.019 and p = 0.01, respectively). Dual infection does not appear to influence levels of HIV-1 viral load in vivo. However, levels of HLA-DR are higher among FSWs dually infected with HIV-1 and HIV-2 than among those infected with HIV-1 only.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018856     DOI: 10.1089/08892220050140919

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

Authors:  R A Otten; D K Smith; D R Adams; J K Pullium; E Jackson; C N Kim; H Jaffe; R Janssen; S Butera; T M Folks
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

Authors:  K Heitzinger; P S Sow; N M Dia Badiane; G S Gottlieb; I N'Doye; M Toure; N B Kiviat; S E Hawes
Journal:  Int J STD AIDS       Date:  2012-10       Impact factor: 1.359

3.  Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa-Salif Sow; Stephen E Hawes; Habibatou Diallo-Agne; Joshua E Stern; Fusheng Li; Andrew L Mesher; Akeliah D Robinson; Geoffrey S Gottlieb; Yunda Huang; Nancy B Kiviat
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

4.  HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.

Authors:  Dana N Raugi; Geoffrey S Gottlieb; Papa S Sow; Macoumba Toure; Fatima Sall; Awa Gaye; Ibra N'doye; Nancy B Kiviat; Stephen E Hawes
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

5.  Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1.

Authors:  Mohamed Mahdi; Zsófia Szojka; János András Mótyán; József Tőzsér
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

6.  A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Authors:  Geoffrey S Gottlieb; Serge-Paul Eholié; John N Nkengasong; Sabelle Jallow; Sarah Rowland-Jones; Hilton C Whittle; Papa Salif Sow
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

7.  The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.

Authors:  Hangxing Yu; Shariq M Usmani; Alexandra Borch; Julia Krämer; Christina M Stürzel; Mohammad Khalid; Xuehua Li; Daniela Krnavek; Marchina E van der Ende; Albert D Osterhaus; Rob A Gruters; Frank Kirchhoff
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602

8.  Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.

Authors:  Birgitta Holmgren; Zacarias da Silva; Pernille Vastrup; Olav Larsen; Sören Andersson; Henrik Ravn; Peter Aaby
Journal:  Retrovirology       Date:  2007-11-27       Impact factor: 4.602

Review 9.  Identifying HIV-1 dual infections.

Authors:  Antoinette C van der Kuyl; Marion Cornelissen
Journal:  Retrovirology       Date:  2007-09-24       Impact factor: 4.602

Review 10.  Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa.

Authors:  Erin Papworth; Nuha Ceesay; Louis An; Marguerite Thiam-Niangoin; Odette Ky-Zerbo; Claire Holland; Fatou Maria Dramé; Ashley Grosso; Daouda Diouf; Stefan D Baral
Journal:  J Int AIDS Soc       Date:  2013-12-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.